Panduratin A mitigates inflammation and oxidative stress in DSS-induced colitis mice model
Aim This study explored Panduratin A’s protective effects against DSS-induced colitis in mice, focusing on reducing inflammation and oxidative stress in the colon.Methods Mice were treated with dextran sodium sulfate (DSS) and Panduratin A (3, 6, 18 mg/kg), and changes in body weight, colon length,...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2024.2428129 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim This study explored Panduratin A’s protective effects against DSS-induced colitis in mice, focusing on reducing inflammation and oxidative stress in the colon.Methods Mice were treated with dextran sodium sulfate (DSS) and Panduratin A (3, 6, 18 mg/kg), and changes in body weight, colon length, Disease Activity Index (DAI), histopathology, inflammation markers including tumor necrosis factor- α (TNF-α), Interleukin-1 β (IL-1β), Myeloperoxidase (MPO), and oxidative stress, Malondialdehyde (MDA) were evaluated.Results Panduratin A significantly reversed DSS-induced symptoms, including body weight loss, colonic length shortening, and DAI increase, while reducing histopathological damage. It lowered inflammatory markers and oxidative stress, suppressed NF-κB activation, and enhanced Nrf2 and HO-1 expression.Conclusion Panduratin A shows promise as a colitis treatment, warranting further research for broader clinical application. |
|---|---|
| ISSN: | 2056-5623 |